Background: Follicular dendritic cell sarcoma (FDCS) is a rare neoplasm arising from follicular dendritic cells of germinal centers. The most common site of origin is lymph nodes and it may mimic a variety of tumors at that location, including carcinomas and sarcomas. Diagnosis is frequently missed on cytology as there are very few case reports describing the cytological characteristics of the lesion. Even on histology, a high degree of suspicion is required for an appropriate diagnosis. Case: A 60-year-old male presented with a gradually increasing left submandibular mass that had been present for 3 months. Fine-needle aspiration cytology (FNAC) was performed, showing many clusters as well as scattered epithelioid cells with spindled to oval nuclei, nuclear pleomorphism, grooves, inclusions, and uniformly dispersed mature lymphocytes throughout the smears. The diagnosis of FDCS was suspected and was confirmed on histopathology and immunohistochemistry. Conclusion: FNAC can be a cheap, easy, and helpful tool in obtaining a diagnosis of FDCS as there are few characteristic cytological features that are better recognized than histology.

Keywords:
Fine-needle aspiration cytology, Follicular dendritic cell sarcoma, Lymph node
1.
Monda L, Warnke R, Rosai J: A primary lymph node malignancy with features suggestive of dendritic reticulum cell differentiation. Am J Pathol 1986;122:562-572.
2.
Mohanty SK, Dey P, Vashishta RK, Rajwanshi A: Cytologic diagnosis of follicular dendritic cell tumor: a diagnostic dilemma. Diagn Cytopathol 2003;29:368-369.
3.
Chan JK, Fletcher CD, Nayler SJ, Cooper K: Follicular dendritic cell sarcoma. Cancer 1997;79:294-313.
4.
Chan J, Pileri S, Delsol G, Fletcher C, Weiss L, Grogg K: Follicular dendritic cell sarcoma; in Swerdlow S, Campo E, Harris N, et al (eds): WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, IARC Press, 2008, pp 363-364.
5.
Wu A, Pullarkat S: Follicular dendritic cell sarcoma. Arch Pathol Lab Med 2016;140:186-190.
6.
Imal Y, Yamakawa M: Morphology, function and pathology of follicular dendritic cells. Pathol Int 1996;46:807-833.
7.
Granados R, Aramburu JA, Rodríguez JM, Nieto MA: Cytopathology of a primary follicular dendritic cell sarcoma of the liver of the inflammatory pseudotumor‐like type. Diagn Cytopathol 2008;36:42-46.
8.
Vicandi B, Jiménez-Heffernan JA, López-Ferrer P, Viguer JM: Fine needle aspiration cytology of follicular dendritic cell sarcoma: a case report. Acta Cytol 2000;44:1106-1110.
9.
Ren R, Sun X, Staerkel G, Sneige N, Gong Y: Fine-needle aspiration cytology of a liver metastasis of follicular dendritic cell sarcoma. Diagn Cytopathol 2005;32:38-43.
10.
Yang GCH, Wang J, Yee HT: Interwoven dendritic processes of follicular dendritic cell sarcoma demonstrated on ultrafast Papanicolaou-stained smears. Acta Cytol 2006;50:534-538.
11.
Fan Y, Ng W, Chan A, Chan GS, Tsang J, Chim C, Ip P: Fine needle aspiration cytology in follicular dendritic cell sarcoma. Acta Cytol 2007;51:642-647.
12.
Czapla A, Omman RA, Nam MW, Mehrotra S, Pambuccian SE: “Medusa-Head” cells, “Starfish” cells, and interconnecting long cytoplasmic processes as diagnostic cytologic clues for follicular dendritic cell sarcoma in fine needle aspiration samples. Diagn Cytopathol 2017;45:322-326.
13.
Chang K, Weiss L: Other histiocytic and dendritic cell neoplasms; in Jaffe E, Harris N, Vardiman J, Campo E, Arber D (eds): Hematopathology, ed 1. Philadelphia, Saunders/Elsevier, 2011, pp 829-833.
14.
Perez-Ordonez B, Erlandson RA, Rosai J: Follicular dendritic cell tumor: report of 13 additional cases of a distinctive entity. Am J Surg Pathol 1996;20:944-955.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.